{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:17:26Z","timestamp":1768565846396,"version":"3.49.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"DOI":"10.1093\/aje\/kwj123","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T09:56:23Z","timestamp":1144317383000},"page":"997-1002","source":"Crossref","is-referenced-by-count":44,"title":["Antibiotic Use and Risk of Multiple Sclerosis"],"prefix":"10.1093","volume":"163","author":[{"given":"Alvaro","family":"Alonso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S.","family":"Jick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hershel","family":"Jick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Hern\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,4,5]]},"reference":[{"key":"key\n\t\t\t\t20171010172249_BIB1","doi-asserted-by":"crossref","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med2000;343:938\u201352.","DOI":"10.1056\/NEJM200009283431307"},{"key":"key\n\t\t\t\t20171010172249_BIB2","doi-asserted-by":"crossref","unstructured":"Layh-Schmitt G, Bendl C, Hildt U, et al. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann Neurol2000;47:652\u20135.","DOI":"10.1002\/1531-8249(200005)47:5<652::AID-ANA15>3.0.CO;2-5"},{"key":"key\n\t\t\t\t20171010172249_BIB3","doi-asserted-by":"crossref","unstructured":"Munger KL, Peeling RW, Hern\u00e1n MA, et al. Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology2003;14:141\u20137.","DOI":"10.1097\/01.EDE.0000050699.23957.8E"},{"key":"key\n\t\t\t\t20171010172249_BIB4","doi-asserted-by":"crossref","unstructured":"Dong-Si T, Weber J, Liu YB, et al. Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis. J Neurol2004;251:542\u20137.","DOI":"10.1007\/s00415-004-0360-0"},{"key":"key\n\t\t\t\t20171010172249_BIB5","doi-asserted-by":"crossref","unstructured":"Boman J, Roblin PM, Sundstrom P, et al. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology2000;54:265.","DOI":"10.1212\/WNL.54.1.265"},{"key":"key\n\t\t\t\t20171010172249_BIB6","doi-asserted-by":"crossref","unstructured":"Gieffers J, Pohl D, Treib J, et al. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis. Ann Neurol2001;49:585\u20139.","DOI":"10.1002\/ana.1020"},{"key":"key\n\t\t\t\t20171010172249_BIB7","doi-asserted-by":"crossref","unstructured":"Derfuss T, Gurkov R, Bergh FT, et al. Intrathecal antibody production against Chlamydia pneumonia in multiple sclerosis is part of a polyspecific immune response. Brain2001;124:1325\u201335.","DOI":"10.1093\/brain\/124.7.1325"},{"key":"key\n\t\t\t\t20171010172249_BIB8","doi-asserted-by":"crossref","unstructured":"Saiz A, Marcos MA, Graus F, et al. No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis. J Neurol2001;248:617\u201318.","DOI":"10.1007\/s004150170141"},{"key":"key\n\t\t\t\t20171010172249_BIB9","doi-asserted-by":"crossref","unstructured":"Villoslada P, Juste C, Tintore M, et al. The immune response against herpesvirus is more prominent in the early stages of MS. Neurology2003;60:1944\u20138.","DOI":"10.1212\/01.WNL.0000069461.53733.F7"},{"key":"key\n\t\t\t\t20171010172249_BIB10","doi-asserted-by":"crossref","unstructured":"Kaufman M, Gaydos CA, Sriram S, et al. Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results. Mult Scler2002;8:289\u201394.","DOI":"10.1191\/1352458502ms815oa"},{"key":"key\n\t\t\t\t20171010172249_BIB11","unstructured":"Jackson LA, Grayston JT. Chlamydia pneumoniae. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone, 2000:2007\u201314."},{"key":"key\n\t\t\t\t20171010172249_BIB12","doi-asserted-by":"crossref","unstructured":"Meier CR, Derby LE, Jick SS, et al. Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA1999;281:427\u201331.","DOI":"10.1001\/jama.281.5.427"},{"key":"key\n\t\t\t\t20171010172249_BIB13","doi-asserted-by":"crossref","unstructured":"Brassard P, Bourgault C, Brophy J, et al. Antibiotics in primary prevention of stroke in the elderly. Stroke2003;34:163\u20136.","DOI":"10.1161\/01.STR.0000085831.91042.BF"},{"key":"key\n\t\t\t\t20171010172249_BIB14","doi-asserted-by":"crossref","unstructured":"Garc\u00eda Rodr\u00edguez LA, P\u00e9rez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol1998;45:419\u201325.","DOI":"10.1046\/j.1365-2125.1998.00701.x"},{"key":"key\n\t\t\t\t20171010172249_BIB15","doi-asserted-by":"crossref","unstructured":"Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ1991;302:766\u20138.","DOI":"10.1136\/bmj.302.6779.766"},{"key":"key\n\t\t\t\t20171010172249_BIB16","doi-asserted-by":"crossref","unstructured":"Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the General Practice Research Database. Pharmacotherapy2003;23:686\u20139.","DOI":"10.1592\/phco.23.5.686.32205"},{"key":"key\n\t\t\t\t20171010172249_BIB17","doi-asserted-by":"crossref","unstructured":"Hern\u00e1n MA, Jick SS, Olek MJ, et al. Recombinant hepatitis B vaccine and the risk of multiple sclerosis. A prospective study. Neurology2004;63:838\u201342.","DOI":"10.1212\/01.WNL.0000138433.61870.82"},{"key":"key\n\t\t\t\t20171010172249_BIB18","doi-asserted-by":"crossref","unstructured":"Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol1983;13:227\u201331.","DOI":"10.1002\/ana.410130302"},{"key":"key\n\t\t\t\t20171010172249_BIB19","doi-asserted-by":"crossref","unstructured":"McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001;50:121\u20137.","DOI":"10.1002\/ana.1032"},{"key":"key\n\t\t\t\t20171010172249_BIB20","doi-asserted-by":"crossref","unstructured":"Poser CM. The epidemiology of multiple sclerosis: a general overview. Ann Neurol1994;36(S2):S180\u2013S93.","DOI":"10.1002\/ana.410360805"},{"key":"key\n\t\t\t\t20171010172249_BIB21","doi-asserted-by":"crossref","unstructured":"Confavreux C. Infections and the risk of relapse in multiple sclerosis. Brain2002;125:933\u20134.","DOI":"10.1093\/brain\/awf146"},{"key":"key\n\t\t\t\t20171010172249_BIB22","doi-asserted-by":"crossref","unstructured":"Marrie RA, Wolfson C, Sturkenboom MC, et al. Multiple sclerosis and antecedent infections. A case-control study. Neurology2000;54:2307\u201310.","DOI":"10.1212\/WNL.54.12.2307"},{"key":"key\n\t\t\t\t20171010172249_BIB23","doi-asserted-by":"crossref","unstructured":"Kozyrskyj AL, Dahl ME, Chateau DG, et al. Evidence-based prescribing of antibiotics for children: role of socioeconomic status and physician characteristics. CMAJ2004;171:139\u201345.","DOI":"10.1503\/cmaj.1031629"},{"key":"key\n\t\t\t\t20171010172249_BIB24","doi-asserted-by":"crossref","unstructured":"Greenhalgh T, Gill P. Pressure to prescribe. BMJ1997;315:1482\u20133.","DOI":"10.1136\/bmj.315.7121.1482"},{"key":"key\n\t\t\t\t20171010172249_BIB25","doi-asserted-by":"crossref","unstructured":"Yong VW, Wells J, Giuliani F, et al. The promise of minocycline in neurology. Lancet Neurol2004;3:744\u201351.","DOI":"10.1016\/S1474-4422(04)00937-8"},{"key":"key\n\t\t\t\t20171010172249_BIB26","doi-asserted-by":"crossref","unstructured":"Munger KL, DeLorenze GN, Levin LI, et al. A prospective study of Chlamydia pneumoniae infection and risk of MS in two cohorts. Neurology2004;62:1799\u2013803.","DOI":"10.1212\/01.WNL.0000125193.58601.2C"},{"key":"key\n\t\t\t\t20171010172249_BIB27","doi-asserted-by":"crossref","unstructured":"Wolfson C, Talbot P. Bacterial infection as a cause of multiple sclerosis. Lancet2002;360:352\u20133.","DOI":"10.1016\/S0140-6736(02)09603-4"},{"key":"key\n\t\t\t\t20171010172249_BIB28","doi-asserted-by":"crossref","unstructured":"Rothstein JD, Patel S, Regan MR, et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature2005;433:73\u20137.","DOI":"10.1038\/nature03180"},{"key":"key\n\t\t\t\t20171010172249_BIB29","doi-asserted-by":"crossref","unstructured":"Werner P, Pitt D, Raine CS. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol2001;50:169\u201380.","DOI":"10.1002\/ana.1077"},{"key":"key\n\t\t\t\t20171010172249_BIB30","doi-asserted-by":"crossref","unstructured":"Srinivasan R, Sailasuta N, Hurd R, et al. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain2005;128:1016\u201325.","DOI":"10.1093\/brain\/awh467"},{"key":"key\n\t\t\t\t20171010172249_BIB31","doi-asserted-by":"crossref","unstructured":"Nau R, Eiffert H. Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev2002;15:95\u2013110.","DOI":"10.1128\/CMR.15.1.95-110.2002"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/163\/11\/997\/401326\/kwj123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T17:01:26Z","timestamp":1555520486000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/aje\/article\/163\/11\/997\/168325\/Antibiotic-Use-and-Risk-of-Multiple-Sclerosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,5]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2006,4,5]]},"published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwj123","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,6,1]]},"published":{"date-parts":[[2006,4,5]]}}}